Soln. Hemomin
Ophthalmic Solution · Ophthalmic · 2% / ophthalmic solution · 10 ml
৳56.55
Soln.
Hemomin
Homatropine Hydrobromide
— Nipa Pharmaceuticals Ltd.
2% / ophthalmic solution
· 10 ml
Presentation
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Mydriasis and cycloplegia for refraction: Adult: Instill 1 or 2 drops of 2% solution, or 1 drop of 5% solution immediately before the procedure, repeat at 5-10 minute intervals if necessary. Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary. Uveitis: Adult: Instill 1-2 drops of 2% or 5% solution bid-tid up to every 3-4 hr as needed. Child: 3 mth- 2 yr: instill 1 drop of 0.5% soln once daily or on alternate days. >2 yr: instill 1 drop of 1% or 2% soln bid.
Clinical notes
Applications:
- Uveitis
Indication Notes:
Homatropine Hydrobromide sterile Eye Drops is indicated for use as a mydriatic and cycloplegic agent.
Avoid In:
N/A
Contraindication Notes:
Contraindicated in patients with closed-angle glaucoma or with a narrow angle between the iris and the cornea.
Homatropine, a tertiary amine antimuscarinic, produces dilation and loss of accommodation by blocking the response of iris sphincter muscle and the accommodative ciliary muscle to cholinergic stimulation.
Effects may be increased by drugs with antimuscarinic effect such as; some antihistamines; phenothiazines; antipsychotics; TCAs; MAOIs or parasympathomimetics.
Hypersensitivity may occur as conjunctivitis.
Ataxia, incoherent speech, restlessness, hallucinations, disorientation, failure to recognize people and tachycardia. Psychotic reactions and behavioural disturbances (in children). SC/IM/IV Physostigmine salicylate 1-2 mg to control central and peripheral effects. Small doses of short-acting barbiturate eg. thiopentone sodium 100 mg to control excitement.
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Matropin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use in lactation: It is not known whether Homatropine is excreted in human milk. Caution should be exercised when Matropin is administered to a nursing mother.
Should be used with caution in patients with prostatic enlargement and in patients suffering from paralytic ileus or pyloric stenosis.
Use in children: Should not be used in children below the age of 3 months